Loading
Pharmacist-health economist serving as 2026-2027 President of ISPOR, the global society for health economics and outcomes research.
Beth Devine, PhD, PharmD, MBA, is President of ISPOR for the 2026-2027 term. Her academic work at the University of Washington focuses on comparative effectiveness research, health technology assessment and the use of real-world evidence in decision making, all of which shape how new oncology therapies are evaluated for value and reimbursement.
| Title | Journal | Year |
|---|---|---|
| Use of geriatric assessment in cancer clinical trials: A systematic review | Journal of Geriatric Oncology | 2022 |
Shares ISPOR (The Professional Society for Health Economics and Outcomes Research) and the tags leadership, health economics.
Shares the tags leadership, health technology assessment.
Shares the tags leadership, health technology assessment.
Shares the tags leadership, health technology assessment.
Shares the tags leadership, health technology assessment.